Ginkgo biloba extract safety: Insights from a real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events
- 30 October 2024
- journal article
- research article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 337 (Pt 3) , 119010
Abstract
No abstract availableKeywords
This publication has 114 references indexed in Scilit:
- Traditional Chinese medicines treat ischemic stroke and their main bioactive constituents and mechanismsPhytotherapy Research, 2023
- The effects of Ginkgo biloba on metabolic syndrome: A reviewPhytotherapy Research, 2020
- Herbal Teas and their Health Benefits: A Scoping ReviewPlant Foods for Human Nutrition, 2019
- Lagos lagoon sediment organic extracts and polycyclic aromatic hydrocarbons induce embryotoxic, teratogenic and genotoxic effects in Danio rerio (zebrafish) embryosEnvironmental Science and Pollution Research, 2016
- Phytoremediation of PAH-Contaminated Areas2014
- Signal detection based on time‐to‐onset: extending a new method from spontaneous reports to observational studiesPharmacoepidemiology and Drug Safety, 2014
- Antioxidant and antiapoptotic effects of proanthocyanidin and ginkgo biloba extract against doxorubicin‐induced cardiac injury in ratsCell Biochemistry and Function, 2012
- Ginkgo biloba for Prevention of DementiaA Randomized Controlled TrialJAMA, 2008
- Allergic contact dermatitis to Ginkgo biloba L.: relationship with urushiolArchives of Dermatological Research, 1989
- Genetic and environmental factors affecting drug disposition in manClinical Pharmacology & Therapeutics, 1977